Latest From Biotech Now

“When Genetic Engineering Came Of Age”

insulin

October 29 was the 30th anniversary of the approval by the Food and Drug Administration (FDA) of human insulin synthesized in genetically engineered bacteria. In an article for Forbes, Henry Miller, the founding director of the FDA’s Office of Biotechnology, marked the anniversary and commented on today’s regulatory environment: “Regulators have adopted a highly risk-averse and even adversarial mindset, few new drugs are approved without convening extramural advisory committees, and decisions are sometimes hijacked by Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Biotech Patenting Event: BIO’s 2012 Fall IPCC in Charleston, South Carolina

charleston

BIO’s 2012 Fall IPCC Conference event on November 12-14 gathers biotech in-house counsels to provide and discuss relevant IP developments.  The Honorable Jimmie V. Reyna, Circuit Judge for the United States Court of Appeals for the Federal Circuit keynotes this year’s program along with the Honorable Judge Sally Gardner Lane, Administrative Patent Judge, Trial Division, Board of Patent Appeals and Interferences. Find program topics and speakers below.  Click here for the full agenda.   Picking the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

It’s World Polio Day – Time to Make History

John Hewko

Oct. 24 is World Polio Day, an opportunity to share a message of extreme importance: The global community must step up now with the resources needed to eradicate this crippling childhood disease once and for all. In all of history, smallpox is the only human disease to be eradicated. It’s time to make global health history a second time by wiping out polio. And that can only happen by reaching every child in every corner Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Pharma & Biotech Companies Donate Hundreds of Millions of Dollars to Copayment Foundations. Here’s Why.

Mary Sundeen

In addition to using their own Patient Assistance Programs, many pharma and biotech companies are supporting independent 501(c)3 non-profit copayment foundations to increase treatment compliance, access to care for insured Americans (including Medicare patients), and to promote proper disease management. Copayment foundations have helped hundreds of thousands of insured Americans afford their coverage and their treatments. The HealthWell Foundation, one of the nation’s largest non-profits, recently issued a white paper on copayment assistance as a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biotech is Growing in Colorado

bioscience_park

Last month I posted a link to an interview featuring Colorado BioScience Association‘s (CBSA) Executive Vice President, April Giles. The interview briefly touched on some of the innovation happening in the state. Though, I was curious to know a bit more about CBSA’s effort to grow and support the industry. So, I was pleased when April kindly agreed to participate in a Q&A. Her answers below offer insight into critical elements of bioscience economic development Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,